Letter by Karasawa and Takahashi Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet"

Affiliations

Comment

Tadayoshi Karasawa et al. Circulation. 2015.

. 2015 Nov 24;132(21):e249.

doi: 10.1161/CIRCULATIONAHA.115.016070.

¹ Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.

No abstract available

Comment in

Response to Letter Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet".
Abderrazak A, Couchie D, Darweesh Mahmood DF, Elhage R, Vindis C, Laffargue M, Matéo V, Büchele B, Ayala MR, Gaafary ME, Syrovets T, Slimane MN, Friguet B, Fulop T, Simmet T, Hadri KE, Rouis M. Abderrazak A, et al. Circulation. 2015 Nov 24;132(21):e250-1. doi: 10.1161/CIRCULATIONAHA.115.017739. Circulation. 2015. PMID: 26596983 No abstract available.

Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet.
Abderrazak A, Couchie D, Mahmood DF, Elhage R, Vindis C, Laffargue M, Matéo V, Büchele B, Ayala MR, El Gaafary M, Syrovets T, Slimane MN, Friguet B, Fulop T, Simmet T, El Hadri K, Rouis M. Abderrazak A, et al. Circulation. 2015 Mar 24;131(12):1061-70. doi: 10.1161/CIRCULATIONAHA.114.013730. Epub 2015 Jan 22. Circulation. 2015. PMID: 25613820